These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 30082724)

  • 1. Clinically prevalent mutations in Mycobacterium tuberculosis alter propionate metabolism and mediate multidrug tolerance.
    Hicks ND; Yang J; Zhang X; Zhao B; Grad YH; Liu L; Ou X; Chang Z; Xia H; Zhou Y; Wang S; Dong J; Sun L; Zhu Y; Zhao Y; Jin Q; Fortune SM
    Nat Microbiol; 2018 Sep; 3(9):1032-1042. PubMed ID: 30082724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic mutations associated with isoniazid resistance in Mycobacterium tuberculosis: a systematic review.
    Seifert M; Catanzaro D; Catanzaro A; Rodwell TC
    PLoS One; 2015; 10(3):e0119628. PubMed ID: 25799046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of Mutations in Genes Related to Rifampicin and Isoniazid Resistance in Multidrug-resistant
    Huang YY; Xie L; Wu YF; Jia QJ; Cheng QL; Li QC; Ai LY; Bai XX
    Biomed Environ Sci; 2023 Sep; 36(9):869-873. PubMed ID: 37803899
    [No Abstract]   [Full Text] [Related]  

  • 4. Diverse Clinical Isolates of Mycobacterium tuberculosis Develop Macrophage-Induced Rifampin Tolerance.
    Adams KN; Verma AK; Gopalaswamy R; Adikesavalu H; Singhal DK; Tripathy S; Ranganathan UD; Sherman DR; Urdahl KB; Ramakrishnan L; Hernandez RE
    J Infect Dis; 2019 Apr; 219(10):1554-1558. PubMed ID: 30753612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genotypic Analysis of Genes Associated with Independent Resistance and Cross-Resistance to Isoniazid and Ethionamide in Mycobacterium tuberculosis Clinical Isolates.
    Rueda J; Realpe T; Mejia GI; Zapata E; Rozo JC; Ferro BE; Robledo J
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7805-10. PubMed ID: 26369965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole-Transcriptome and -Genome Analysis of Extensively Drug-Resistant Mycobacterium tuberculosis Clinical Isolates Identifies Downregulation of
    de Welzen L; Eldholm V; Maharaj K; Manson AL; Earl AM; Pym AS
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28993337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations of rpoB, katG, inhA and ahp genes in rifampicin and isoniazid-resistant Mycobacterium tuberculosis in Kyrgyz Republic.
    Isakova J; Sovkhozova N; Vinnikov D; Goncharova Z; Talaibekova E; Aldasheva N; Aldashev A
    BMC Microbiol; 2018 Mar; 18(1):22. PubMed ID: 29566660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome sequencing of Mycobacterium tuberculosis clinical isolates revealed isoniazid resistance mechanisms undetected by conventional molecular methods.
    Laurent S; Zakham F; Bertelli C; Merz L; Nicod L; Mazza-Stalder J; Greub G; Jaton K; Opota O
    Int J Antimicrob Agents; 2020 Aug; 56(2):106068. PubMed ID: 32603684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular characterization of multidrug-resistant Mycobacterium tuberculosis isolated in Nepal.
    Poudel A; Nakajima C; Fukushima Y; Suzuki H; Pandey BD; Maharjan B; Suzuki Y
    Antimicrob Agents Chemother; 2012 Jun; 56(6):2831-6. PubMed ID: 22450970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [GenoType MTBDR plus 1.0® for the detection of cross-resistance between isoniazide and ethionamide in isolates of multidrug-resistant Mycobacterium tuberculosis].
    Rueda J; Realpe T; Mejía G; Zapata E; Robledo J
    Biomedica; 2015; 35(4):541-8. PubMed ID: 26844443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Occurrence of disputed rpoB mutations among Mycobacterium tuberculosis isolates phenotypically susceptible to rifampicin in a country with a low incidence of multidrug-resistant tuberculosis.
    Al-Mutairi NM; Ahmad S; Mokaddas E; Eldeen HS; Joseph S
    BMC Infect Dis; 2019 Jan; 19(1):3. PubMed ID: 30606116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycobacterium tuberculosis whole genome sequencing and protein structure modelling provides insights into anti-tuberculosis drug resistance.
    Phelan J; Coll F; McNerney R; Ascher DB; Pires DE; Furnham N; Coeck N; Hill-Cawthorne GA; Nair MB; Mallard K; Ramsay A; Campino S; Hibberd ML; Pain A; Rigouts L; Clark TG
    BMC Med; 2016 Mar; 14():31. PubMed ID: 27005572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in rpoB and katG genes of multidrug resistant mycobacterium tuberculosis undetectable using genotyping diagnostic methods.
    Takawira FT; Mandishora RSD; Dhlamini Z; Munemo E; Stray-Pedersen B
    Pan Afr Med J; 2017; 27():145. PubMed ID: 28904673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of rpoB, katG and inhA gene mutations in Mycobacterium tuberculosis clinical isolates from Chongqing as determined by microarray.
    Yao C; Zhu T; Li Y; Zhang L; Zhang B; Huang J; Fu W
    Clin Microbiol Infect; 2010 Nov; 16(11):1639-43. PubMed ID: 20491829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rational Design of Biosafety Level 2-Approved, Multidrug-Resistant Strains of Mycobacterium tuberculosis through Nutrient Auxotrophy.
    Vilchèze C; Copeland J; Keiser TL; Weisbrod T; Washington J; Jain P; Malek A; Weinrick B; Jacobs WR
    mBio; 2018 May; 9(3):. PubMed ID: 29844114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotyping and molecular characteristics of multidrug-resistant Mycobacterium tuberculosis isolates from China.
    Zhang Z; Lu J; Liu M; Wang Y; Qu G; Li H; Wang J; Pang Y; Liu C; Zhao Y
    J Infect; 2015 Apr; 70(4):335-45. PubMed ID: 25485999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of first-line antimicrobial resistance in multi-drug and extensively drug resistant strains of Mycobacterium tuberculosis in KwaZulu-Natal, South Africa.
    Dookie N; Sturm AW; Moodley P
    BMC Infect Dis; 2016 Oct; 16(1):609. PubMed ID: 27784282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of combined gene mutations in inhA and ahpC genes on high levels of isoniazid resistance amongst katG non-315 in multidrug-resistant tuberculosis isolates from China.
    Liu L; Jiang F; Chen L; Zhao B; Dong J; Sun L; Zhu Y; Liu B; Zhou Y; Yang J; Zhao Y; Jin Q; Zhang X
    Emerg Microbes Infect; 2018 Nov; 7(1):183. PubMed ID: 30446638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of reasons of the MDR M. tuberculosis strains dissemination by analysis of the rifampicin and/or isoniazid resistant isolates].
    Sivkov AIu; Boldyrev AN; Azaev MSh; Bodnev SA; Medvedeva EV; Baranova OI; Ivlev-Dantau AP; Blinova LN; Pasechnikov AD; Tat'kov SI
    Mol Gen Mikrobiol Virusol; 2006; (2):20-5. PubMed ID: 16755998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of novel mutations associated with independent resistance and cross-resistance to isoniazid and prothionamide in Mycobacterium tuberculosis clinical isolates.
    Islam MM; Tan Y; Hameed HMA; Liu Z; Chhotaray C; Liu Y; Lu Z; Cai X; Tang Y; Gao Y; Surineni G; Li X; Tan S; Guo L; Cai X; Yew WW; Liu J; Zhong N; Zhang T
    Clin Microbiol Infect; 2019 Aug; 25(8):1041.e1-1041.e7. PubMed ID: 30583053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.